1. SO-007Regorafenib plus nivolumab in patients with advanced colorectal or gastric cancer: an open-label, dose-finding, and dose-expansion phase 1b trial (REGONIVO, EPOC1603). (2nd July 2019) Authors: Hara, H; Fukuoka, S; Takahashi, N; Kojima, T; Kawazoe, A; Asayama, M; Yoshii, T; Kotani, D; Tamura, H; Mikamoto, Y; Sugama, A; Wakabayashi, M; Nomura, S; Sato, A; Togashi, Y; Nishikawa, H; Shitara, K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗